🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Tirzepatide

Study of Tirzepatide for Recovery and Alcohol Use Management NCT06727331Phase 22 sites📍 Boston📍 Jamaica Plain Brigham and Women's Hospital · Tests: Tirzepatide, Saline Placebo PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Tirzepatide Tirzepatide Impact Assessment Study NCT07740291NA1 site📍 Lubbock Texas Tech University · Tests: GLP-1 Receptor Agonist Therapy, Structured Lifestyle Intervention A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity NCT07803744Phase 11 site📍 Miami Eli Lilly and Company · Tests: Tirzepatide, Acetaminophen, Placebo Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 NCT07091734Phase 21 site📍 Ann Arbor University of Michigan · Tests: Tirzepatide, Usual care medications Tirzepatide for Alcohol Use Disorder NCT06994338Phase 21 site📍 Los Angeles University of Southern California · Tests: Tirzepatide, Placebo injections Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS) NCT07817875Phase 382 sites📍 Tucson📍 Loma Linda📍 Los Angeles Eli Lilly and Company · Tests: Tirzepatide, Placebo Tirzepatide Weight Loss for MRD+ Early Breast Cancer NCT06517212Phase 21 site📍 Dallas Baylor Research Institute · Tests: Tirzepatide Multi-Site Trial of Tirzepatide for Smoking Cessation NCT07602699Phase 24 sites📍 Los Angeles📍 Aurora📍 New Haven University of Southern California · Tests: Tirzepatide, Placebo Tirzepatide (Spartina) in Obese Kidney Transplant Recipients NCT07423247Phase 41 site📍 Tehran Shahid Beheshti University of Medical Sciences · Tests: Tirzepatide Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. NCT07588438Phase 41 site📍 Asunción Las Rías Medical Center · Tests: Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.) Tirzepatide vs Liraglutide in Bone NCT07094568n/a1 site📍 Athens National and Kapodistrian University of Athens Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative Study NCT07866183NA1 site📍 Moscow National Medical Research Center for Therapy and Preventive… · Tests: Tirzepatide, Transcutaneous auricular vagus nerve stimulation Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT NCT05708859Phase 41 site📍 Torrance Matthew J. Budoff · Tests: Tirzepatide, Placebo Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study NCT06937086Phase 3187 sites📍 Dothan📍 Anaheim📍 Beverly Hills Eli Lilly and Company · Tests: Mirikizumab, Mirikizumab, Tirzepatide, Placebo A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication NCT07868354Phase 12 sites📍 Glendale📍 Baltimore Novo Nordisk A/S · Tests: Tirzepatide, Zenagamtide Tirzepatide for Treatment of CCCA NCT07734870Phase 22 sites📍 Baltimore📍 Columbia Johns Hopkins University · Tests: Tirzepatide Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide NCT07777575Phase 41 site📍 München Technical University of Munich · Tests: Dual GIP/GLP-1 Receptor Agonist Tirzepatide, Resistance Training Tirzepatide Use in People With Obesity and Type 1 Diabetes NCT07096908Phase 41 site📍 Kuwait City Dasman Diabetes Institute · Tests: Tirzepatide, Placebo GLP-1R Actions on Muscle and the Skeleton NCT07154719Phase 42 sites📍 Baton Rouge📍 Scarborough Pennington Biomedical Research Center · Tests: Tirzepatide, Lifestyle toolkit The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease NCT06606821Phase 43 sites📍 Copenhagen📍 Gentofte Municipality📍 Herlev Tina Vilsbøll · Tests: Tirzepatide, Placebo LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy NCT06885736NA1 site📍 Kuwait City Dasman Diabetes Institute · Tests: Resistance exercise, Protein Intake Effect of Tirzepatide on Markers of MASLD in Patients With Obesity NCT06934642EARLY Phase 11 site📍 Albuquerque University of New Mexico · Tests: Tirzepatide A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults NCT07364175NA1 site📍 Cambridge Cambridge University Hospitals NHS Foundation Trust · Tests: Tirzepatide, Anti-Hypertensive medications MAINTAIN (Mucosal AblatIoN Therapy After INcretins) NCT06734312NA2 sites📍 Cary📍 Cary Dr. Christopher McGowan · Tests: Gastric Fundal Mucosal Ablation (GFMA) A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide NCT06897475Phase 260 sites📍 Phoenix📍 Santa Ana📍 Ocala Eli Lilly and Company · Tests: LY3457263, Placebo Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer NCT06518837Phase 27 sites📍 Elizabeth📍 Hamilton📍 Livingston Rutgers, The State University of New Jersey · Tests: Tirzepatide Tirzepatide in PWS, HO and GNSO NCT06901245Phase 43 sites📍 Saint Paul📍 Nashville📍 Seattle Grace Kim · Tests: Tirzepatide Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation NCT07387796NA1 site📍 Dallas The University of Texas at Dallas · Tests: Discontinuation and Reinitiation of Tirzepatide Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity NCT07574723NA1 site📍 Kuwait City Dasman Diabetes Institute · Tests: Tirzepatide (Per-label titration), Tirzepatide (Flexible titration)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy